HLS Therapeutics, Inc. (HLS.TO)
4.59
+0.04
(+0.88%)
CAD |
TSX |
May 29, 16:00
HLS Therapeutics Shareholders Equity (Quarterly) : 81.74M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | -2.873B |
| Cipher Pharmaceuticals, Inc. | 185.25M |
| BioSyent, Inc. | 44.99M |
| Revive Therapeutics Ltd. | -3.74M |
| Knight Therapeutics, Inc. | 787.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.94M |
| Total Liabilities (Quarterly) | 101.20M |
| Debt to Equity Ratio | 0.75 |
| Current Ratio | 1.004 |
| Net Debt Paydown Yield | 5.01% |